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Barrier membranes are used in periodontal applications with the aim of supporting periodontal regener-
ation by physically blocking migration of epithelial cells. The present work proposes a combination of
chitosan (CHT) with bioactive glass nanoparticles (BG-NPs) in order to produce a novel guided tissue
and bone regeneration membrane, fabricated by solvent casting. The CHT/BG-NP nanocomposite mem-
branes are characterized in terms of water uptake, in mechanical tests, under simulated physiological
conditions and in in vitro bioactivity tests. The addition of BG-NPs to CHT membranes decreased the
mechanical potential of these membranes, but on the other hand the bioactivity improved. The mem-
branes containing the BG-NPs induced the precipitation of bone-like apatite in simulated body ﬂuid
(SBF). Biological tests were carried out using human periodontal ligament cells and human bone marrow
stromal cells. CHT/BG-NP composite membranes promoted cell metabolic activity and mineralization.
The results indicate that the CHT/BG-NP composite membrane could potentially be used as a temporary
guided tissue regeneration membrane in periodontal regeneration, with the possibility to induce bone
regeneration.
 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Periodontitis is an inﬂammatory disease of the periodontal tis-
sues, caused by microorganisms and calculus accumulation on the
bacterial bioﬁlm, leading to degradation of the connective tissues
and alveolar bone and subsequent formation of soft tissue pockets
around the root surface [1]. Regeneration of the periodontal region
is challenged by complex inﬂammatory processes and events re-
lated to healing, resulting in unsatisfactory results in clinical cases
using the currently available therapies. Ideal strategies should be
able to regenerate all damaged structures including the cementum,
periodontal ligament and alveolar bone. The number of cells occu-
pying the treated area upon surgery as well as the size of the defect
determine the type of connection formed between the cementum
and bone. Epithelial cells are the ﬁrst cells to migrate to the site
of injury becoming a problem as they prevent bone formation.ia Inc. Published by Elsevier Ltd. A
Biomaterials, Biodegradables
of the European Institute of
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.The guided tissue regeneration (GTR) technique uses a membrane,
which acts as a barrier to prevent epithelial cells and gingival tis-
sue reaching the area of injured tissue [2]. This procedure favors
the regeneration of lost and damaged tissue, as it promotes cell
repopulation of the periodontal ligament and adjacent alveolar
bone, allowing the necessary time for osteoblast proliferation and
bone regeneration [3,4]. Cells derived from adult human bone mar-
row stromal cells (hBMSC) are capable of contributing to the for-
mation of new bone completely surrounding the tooth, which
has to be able to anchor itself to the jaw through its roots and peri-
odontal ligament [5]. The continuing process of periodontal tissue
repair is followed by the formation of granulation tissue as a source
of future periodontal connective tissue cells, such as osteoblasts,
periodontal ligament ﬁbroblasts and cementoblasts [5]. Thus hu-
man periodontal ligament cells (hPDL) and hBMSCs are ideal cell
sources to be used in biological tests to evaluate the performance
of GTR membranes.
When selecting an ideal biomaterial for GTR membranes the
following requirements must be considered: wound stabilization,
space creation and maintenance, protection of the underlying
blood clot, and the ability to exclude unwanted tissues or cells
(connective tissue and gingival epithelium). Collagen has beenll rights reserved.
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branes. However, this material is derived from animal sources
and has an associated risk of disease transmission and associated
ethical and cultural issues. Moreover, the fast resorption rate of
this material and its poor mechanical strength are a concern to
many clinicians. In addition, rapid collagen biodegradation, by
the enzymatic activity of macrophages, polymorphonuclear leuco-
cytes and several pathogens capable of producing collagenase,
results in a limited membrane resistance to collapse. This event
allows unwanted cell types to enter the wound area [6]. Since
collagen membranes have shown such limited properties, new
materials with better properties are required.
Chitosan (CHT) is obtained by alkaline deacetylation of chitin
and presents excellent biological properties, such as biodegradabil-
ity, biocompatibility, and immunogenicity, as well as antibacterial,
antifungal and wound-healing activity. Its degradation products
are non-toxic, non-antigenic, non-immunogenic and non-carcino-
genic. CHT also evokes minimal foreign body reaction [7–12]. The
positive surface charge of this biomaterial and its biocompatibility
enable it to effectively support cell growth, while the hydrophilic
surface facilitates cell adhesion, proliferation, and differentiation
[7,11,13]. When placed in hydrated environments CHT is a ﬂexible
material. This is an advantage over more rigid synthetic materials
like polylactic acid (PLA) and polyglycolic acid (PGA), facilitating
handling during the implantation process [14–16]. Because of
these properties CHT has been widely used in biomedical applica-
tions [9,12,13,17]. It can accelerate wound healing and enhance
bone formation both in vivo and in vitro. It has been reported that
when implanted in vertebrates it may enhance the migration and
differentiation of speciﬁc types of progenitor cells (e.g. osteoblast
differentiation) [10,18,19]. Lahiji et al. found that CHT may serve
as an effective template in the repair of osseous defects, because
it has unique material properties and the ability to support viable
and functioning human osteoblasts. [9] Thus CHT is an attractive
candidate for future use in GTR membranes. However, CHT is not
an ideal material for bone regeneration, as its osteoconductivity
needs to be improved. Zhang et al. [20] veriﬁed that no apatite
was formed on the surface of pure CHT scaffolds. To improve the
bioactivity of CHT it is necessary to combine it with other bioactive
materials [21]. Recent studies have highlighted the importance of
the development of composite materials based on biodegradable
polymers containing bioactive glasses [22]. Bioactive glasses often
show excellent bioactivity and biocompatibility both in vitro and
in vivo: when implanted at the site of bone defects they can di-
rectly bond to the surrounding tissues by chemical linkage. As well
as the GTR function, acting as a barrier, the addition of bioactive
glass particles to CHT membranes should promote guided bone
regeneration (GBR) activity, giving a dual function, producing a
GTR/GBR membrane. The biomineralization capability of bioactive
glasses is related to its composition, but is also inﬂuenced by phys-
ical properties such as particle size, porosity, surface area and mor-
phology. In recent years a growing consensus has been reached to
concentrate on the development of nanostructural bioactive glass/
ceramic materials, due to their high biomineralization capability.
Large surface area bioactive glass materials should facilitate bone
healing and tooth defects, as well as blood clotting. Consequently,
the preparation and application of nanoscale bioactive glass mate-
rials has received increasing attention from biological material
researchers. The sol–gel method has been used to prepare high
surface area bioactive glass particles, including bioactive glass
nanoparticles (BG-NPs) [10,23–26].
In this study CHT/BG-NP nanocomposite membranes were pre-
pared by solvent casting, and the physical, bioactive and biological
properties of these biomaterials were characterized, to evaluate
the possible performance in periodontal defect applications, using
hPDL and hBMSC cells in biological tests.2. Materials and methods
Chitosan (CHT) (Mw 190,000–310,000, 75–85% deacetylated,
viscosity 200–800 cps) was obtained from Sigma and was puriﬁed
before use. Tetraethyl orthosilicate (TEO) (99.90% pure), ammo-
nium phosphate dibasic, calcium nitrate tetrahydrate (99%), citric
acid monohydrate (99–100%), ammonium hydroxide (maximum
33% NH3) and all chemicals for SBF preparation were purchased
from Sigma–Aldrich. All other reagents and solvents used were of
reagent grade.
2.1. Bioactive glass nanoparticle preparation
To prepare the BG-NPs a protocol based on previous work was
followed [27,28]. The procedure to obtain nanoparticles with the
composition SiO2:CaO:P2O5 (mol.%) = 55:40:5 consisted of sequen-
tial reagent dissolution that resulted in hydrolysis and polyconden-
sation reactions. TEOS (99.90% pure) was used as the silicon
precursor, ammonium phosphate dibasic as the phosphorus pre-
cursor, calcium nitrate tetrahydrate (99%) as the calcium precursor,
citric acid monohydrate (99–100%) to promote hydrolysis, absolute
ethanol, ammonium hydroxide (maximum 33% NH3) as the gelling
agent and polyethylene glycol 20,000 (PEG) as the surfactant. The
BG-NPs were sintered at 700 C for 5 h. Spherical particles with
sizes below 50 nm were obtained (see Fig. 3).
2.2. Membrane preparation
Composite membranes were obtained by the dissolution of 0.7%
(w/v) puriﬁed CHT and 0.3% (w/v) BG-NPs in a solution of 2 vol.%
acid acetic. Pure CHT membranes were obtained by dissolution of
1% (w/v) CHT in a solution of 2 vol.% acid acetic. After complete sol-
vent evaporation the membranes were neutralized with a solution
of 0.4% (w/v) NaOH and left to dry at room temperature.
2.3. Water uptake
1  1 cm samples cut from the membranes were weighted
(Wini) and then immersed at 37 C in 2 ml of phosphate-buffered
saline (PBS), pH 7.4, containing 0.8% (w/v) lysozyme (hen egg-
white) and 0.02% (w/v) sodium azide. The concentration of
lysozyme was similar to the concentration in human serum [29].
Membranes of known dry weight (n = 3 samples of each set of
membranes) were incubated in the lysozyme solution for the per-
iod of study. At each time point samples were removed from the
solution and rinsed with distilled water. The superﬁcial water
was removed and samples were weighted (Wﬁn). The water uptake
was calculated using the equation:
ðW fin W iniÞ=W ini  100 ð%Þ2.4. Mechanical tests
The ultimate tensile strength (UTS) and tensile modulus of the
membranes were determined using an Instron 4505 Universal Ma-
chine tensile testing machine in tensile mode. The tests were per-
formed at room temperature at a rate of 5 mmmin1. Wet
membranes were immersed in PBS for 3 h before the test and were
ﬁxed with sandpaper, to prevent slipping. Tests were performed on
a single membrane with a gauge length of 10 mm. For each condi-
tion a minimum of ﬁve specimens were tested.
2.5. In vitro bioactivity tests
In vitro bioactivity tests were carried out by soaking the mem-
branes in 50 ml of SBF for 5 days at 37 C. The SBF composition and
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[30]. Upon removal from the SBF the samples were rinsed with
distilled water and left to dry.
2.6. Scanning electron microscopy (SEM) and energy dispersive
spectroscopy (EDX) experiments
A NanoSEM FEI Nova 200 (FEG/SEM) scanning electron micro-
scope was used to study the surface and the morphology of the
samples. A conductive gold coating was applied to the samples
prior to observation. A Pegasus X4M instrument was used to pre-
form the energy dispersive X-ray spectroscopy (EDX) experiments,
in a low vaccum and without coating.
2.7. Cell culture
Periodontal ligament cells were obtained from human third
molars according to the following procedure. After extraction the
teeth were washed three times for 10 min in PBS with
100 units ml1 penicillin/streptomycin. Periodontal ligament tis-
sue was scraped from the middle third of the root with a scalpel
blade, to avoid contamination by epithelial or pulp cells. The freed
portions of the periodontal ligament were minced and transferred
to a small culture ﬂask, which was ﬁlled with alpha minimal essen-
tial medium (a-MEM) (Gibco) containing 10 vol.% fetal calf serum
(FCS) (Gibco), 50 mg ml1 ascorbic acid (Sigma), 10.8 M dexameth-
asone (Sigma), 50 mg ml1 gentamycin (Gibco) and 10 mM sodium
b-glycerophosphate (Sigma). Cells were cultured at 37 C in a
humidiﬁed atmosphere with 5% CO2. The medium was replaced
every 2–3 days. Upon reaching 100% conﬂuency the cells were re-
leased with trypsin/EDTA (0.25% w/v crude trypsin and 1 mM
EDTA, pH 7.2) and sub-cultured for two passages in standard cul-
ture ﬂasks. The cells were then frozen in liquid nitrogen until use.
hBMSCs were isolated from bone blocks of human iliac crest
biopsies. The biopsies were discarded tissue from standard surgical
procedures at Radboud University Nijmegen Medical Centre
(Nijmegen, The Netherlands). The bone blocks were cut into small
pieces and subsequently placed in a 50 ml tube to which 20 ml of
a-MEM was added. Then the tubes were shaken vigorously and
the medium with cells collected. This procedure was repeated sev-
eral times. The collected medium with cells was plated in T25 cul-
ture ﬂasks (Greiner Bio-one), which were ﬁlled with 4 ml of a-MEM
containing 10 vol.% FCS and 100 units ml-1 penicillin/streptomycin
(all from Gibco BRL Life Technologies BV, Breda, The Netherlands).
The cells were cultured at 37 C in a humid atmosphere with 5%
CO2 and passaged at 80% conﬂuency using trypsin/EDTA (Gibco).
Two kinds of proliferation medium were used (hereafter re-
ferred to as O culture media). The hPDL O culture medium was
composed of a-MEM (Gibco) with 10% fetal bovine serum (FBS)
(Greiner Bio-one) and 100 units ml1 penicillin/streptomycin (Gib-
co BRL). The hBMSC O culture medium was composed of a-MEM
(Gibco) with 15% FBS (Greiner Bio-one), 1% L-glutamine, 1% ascor-
bic acid (Sigma), 100 units ml1 penicillin/streptomycin (Gibco
BRL) and 1%, by volume added to each cell culture ﬂask, basic ﬁbro-
blast growth factor (bFGF).
After one generation the cells were plated at a density of
5000 cells cm2 in T75 culture ﬂasks and expanded in O culture
medium. The culture medium was changed twice a week. Cells
from passage 3 were used in this experiment.
2.8. Cell seeding
The membranes were glued to metal rings (1.5 cm diameter)
with RTV silicone adhesive (Nusil Technology, Carpinteria, CA), in
order to prevent membrane ﬂuctuation and to ﬁx them on the cul-
ture well bottom. The samples were sterilized by immersion in 70%ethanol for 1 h, rinsed in PBS and soaked in medium overnight.
Cells, either hPDL or hBMSC, were seeded on the samples and after
4 h (at 37 C and 5% of CO2) osteogenic differentiation culture med-
ium (O+ culture medium) was added. As controls cells were seeded
directly on the bottom of the plate and O+ culture medium was
added immediately.
Two types of O+ culture medium were used. The hPDL O+ cul-
ture medium was composed of a-MEM (Gibco) with 10% FBS (Gre-
iner Bio-one), 1% ascorbic acid (Sigma), 1% b-glycerophosphate
(Sigma), 1% dexamethasone (Sigma) and 100 units ml1 penicil-
lin/streptomycin (Gibco BRL). The hBMSC O+ culture medium was
composed of a-MEM (Gibco) with 15% FBS (Greiner Bio-one), 1%
L-glutamine, 1% ascorbic acid (Sigma), 1% b-glycerophosphate (Sig-
ma), 1% dexamethasone (Sigma) and 100 units ml1 penicillin/
streptomycin (Gibco BRL).
2.9. Biological tests
2.9.1. Immunoﬂuorescence and image analyses
After 3 days in culture on the membrane surface cells were
ﬁxed for 10 min in 3% paraformaldehyde (Fluka AG), and perme-
abilized with 1% Triton X-100 for 5 min. Then ﬁlamentous actin
was stained with AlexaFluor 568 phalloidin (Molecular Probes
Inc., Eugene, OR) diluted 1:200 in PBS containing 1% bovine serum
albumin (BSA) for 2 h. The cells nuclei were stained with 4,6-
diamidino-2phenylindole (DAPI) diluted 1:2500 in PBS for
10 min. Finally, the specimens were examined with a Zeiss auto-
mated ﬂuorescence microscope (Imager Z1) at a magniﬁcation of
10.
2.9.2. Proliferation assay
After the various experimental periods the medium was re-
moved from the chambers and the wells were washed with PBS.
The cells were lysed using milliQ ﬁltered water with subsequent
sonication for 10 min between two freeze–thaw cycles at 80 C.
The supernatant was stored at 20 C until further analysis. A Pico-
Green dsDNA Quantiﬁcation Kit (Molecular Probes, Eugene, OR)
was used according to the manufacturer’s instructions. The analy-
sis was performed on the supernatants from days 1, 3, 7, 14 and 28.
100 ll of PicoGreen working solution was added to 100 ll of each
supernatant sample. The samples were incubated for 2–5 min at
room temperature in the dark. After incubation ﬂuorescence was
measured in a ﬂuorescence cuvette reader (microplate ﬂuores-
cence reader, Bio-Tek Instruments, Winooski, VT) with a 485 nm
excitation ﬁlter and a 530 nm emission ﬁlter.
2.9.3. Alamar blue
Cell metabolic activity was measured using the Alamar blue as-
say (Invitrogen) according to the manufacturer’s instructions. A
solution was made of Alamar blue in culture medium in the pro-
portions 1:9 and held at 37 C for 5 min. Culture medium was
ﬂushed fromwells containing samples with cells and replaced with
the test solution. Culture plates were incubated at 37 C in 5% CO2
for 4 h. After incubation 200 ll of each sample solution were trans-
ferred to 96-well plates (Greiner Bio-one). Fluorescence was mea-
sured using a microplate reader (FL 600, Bio-Tek Instruments) at
570 nm. The assay was performed on days 1, 3, 7, 14 and 28.
2.9.4. Calcium content measurement
Calcium content was assessed 28 days after cell seeding to
obtain information on mineralized matrix formation. The samples
were rinsed with milliQ ﬁltered water and 1 ml of acetic acid was
added. The samples were incubated overnight under vigorous
constant shaking and the acetic acid with dissolved calcium
was frozen and kept at 20 C until further investigation.
After thawing the calcium content was determined using the OCPC
Fig. 2. Stress–strain representative curves of pure CHT and CHT/BG-NP composite
membranes in (a) dry and (b) wet conditions.
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with an ELISA reader (Bio-Tek Instruments, Winooski, VT) at a
wavelength of 570 nm.
2.10. Statistical analysis
Every sample was measured in triplicate. Statistical analysis
was performed using an unpaired ordinary ANOVA, using standard
parametric methods, and Tukey’s test. Calculations were per-
formed in InStat (v.3.0 GraphPad Software Inc., San Diego, CA).
3. Results and discussion
3.1. Water uptake
Homogeneous membranes were produced using the solvent
casting methodology described above. Water uptake measurement
curves for the CHT/BG-NP composites and pure CHT membranes
are shown in Fig. 1.
From Fig. 1 it can be seen that swelling reached equilibrium
after 5 min immersion in the cocktail solution. The water uptake
values are similar for both pure CHT and the CHT/BG-NP composite
membranes, of the order of 130%. This behavior is similar to the re-
sults found before for CHT membranes prepared by a similar meth-
odology, in which swelling equilibrium took place after 15 min
[31]. No signiﬁcant changes in water uptake were detected over
a period of 16 weeks, which is consistent with the stability of
weight loss over 14 weeks, indicating slow degradation in vitro
(data not shown). Ren et al. [32] obtained similar CHT water uptake
values to this study of 130%, without signiﬁcant variations over
time [32]. Peter et al. [33,34] measured the swelling of CHT and
CHT with bioactive glass ceramic scaffolds in the same way as in
this study. However, a signiﬁcant reduction in water uptake was
found on the addition of nanoparticles to the scaffolds at one time
point [33,34]. In contrast, Maquet et al. [35,36] showed that the
addition of BG-NPs to a polymer increased water absorption.
3.2. Tension tests
Tensile testing under dry and wet conditions was conducted to
evaluate the mechanical properties of both the CHT and CHT/BG-
NP composite membranes (see Fig. 2 and Table 1). Biomedical im-
plants are usually placed in very hydrated environments, which
may signiﬁcantly inﬂuence their performance compared with the
dry state. The mechanical behavior under wet conditions is very
important in predicting the mechanical properties of membranes
in vivo, which determine both their clinical operation and bone
healing capacity [37,38].
Representative stress–strain curves from tensile tests obtained
for pure CHT and CHT/BG-NP composite membranes, under both
dry and wet conditions, are presented in Fig. 2. The corresponding
tensile properties of the membranes are summarized in Table 1.
Signiﬁcant differences were found for pure CHT and CHT/BG-NP
composite membranes when comparing dry and wet conditions.Fig. 1. Water uptake evaluation of the CHT/BG-NP composite and the pure CHT
membranes over a period of 16 weeks.In wet conditions both the Young’s modulus and UTS decreased
signiﬁcantly compared with the dry state for both types of mem-
brane. On the other hand, in the same conditions the elongation
at failure increases by around one order of magnitude. Silva et al.
also found large decreases in the secant modulus and stress at fail-
ure for pure CHT membranes, and a large increase in strain at fail-
ure upon hydration [31]. In others studies the stiffness of similar
CHT membranes systematically decreased with increasing humid-
ity, with reduction by a factor of greater than 50 relative to the dry
state [39,40]. On the addition of BG-NPs to CHT membranes an in-
crease in stiffness was observed under both dry and wet condi-
tions. The strength of the membrane and the elongation at
failure also tend to decrease with the presence of BG-NPs under
both environmental conditions. Xianmiao et al. [38] and Teng
et al. [41] performed similar studies to evaluate the properties of
nanohydroxyapatite/CHT membranes, showing that the addition
of nanohydroxyapatite to CHT decreased both the tensile strength
and elongation at failure, but increased the elastic modulus. The
membranes were much more ﬂexible under wet conditions. Even
with the introduction of an inorganic phase the composite mem-
branes could sustain a deformation of greater than 70% in wet
conditions.3.3. In vitro bioactivity tests
In this study nanoparticles were used in the preparation of the
composites (see inset in Fig. 3b). As shown in the inset in Fig. 3b
the BG-NPs have a spherical, somewhat interconnected appear-
ance, with particle sizes in the range 30–50 nm.
In vitro bioactivity tests were performed on both the pure CHT
and composite membranes. No apatite layer formed on the CHT
membrane surface after soaking in SBF for 5 days (see Fig. 3a).
Before soaking in SBF the surface of the composite membrane
containing 30% BG-NPs showed some protuberances that could
indicate some agglomeration of the BG-NPs (see Fig. 3b). The
bioactive potential of the composite membranes produced was
conﬁrmed by the development of an apatite layer after immersion
in SBF for 5 days (see SEM image in Fig. 3c). Fig. 3d shows needle-
like crystals arranged in typical cauliﬂower-like clusters.
The EDX data presented in Fig. 4 shows that the silicon (Si)
content of the composite membranes decreased after 5 days in
SBF, followed by an increase in calcium (Ca) and phosphorous
(P). The increases in Ca and P, accompanied by a decrease in the
Table 1
Mechanical properties of pure CHT membranes and CHT/BG-NP composite membranes under wet and dry conditions.
Membranes Young’s modulus (MPa) Ultimate tensile strength (MPa) Elongation at break (%) Water uptake (%)
Dry Wet Dry Wet Dry Wet
CHT 1858 ± 82 4.0 ± 0.4 56.7 ± 3.9 6.3 ± 0.8 16.8 ± 5.3 153.2 ± 18.7 145 ± 36
CHT/BG-NP 2639 ± 212 4.7 ± 0.3 49.6 ± 9.2 3.3 ± 0.6 2.5 ± 0.6 71.6 ± 11.6 130 ± 9
(a) (b)
(c) (d)
µm
Fig. 3. SEM images of (a) pure CHT membranes immersed in SBF for 5 days, (b) 70% CHT–30% BG-NP membranes before soaking in SBF, and (c, d) 70% CHT–30% BG-NP
membranes immersed in SBF for 5 days at low and high magniﬁcation, respectively. The inset in (b) shows the morphology of the BG-NPs.
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apatite, being consistent with the SEM observations [42].
The ﬁrst reaction of bioactive glasses soaked in SBF is ion ex-
change, in which Ca2+ and Na+ in the glass exchange with H3O+
in the solution, resulting in a solution pH increase as well as in
the formation of a hydrated silica gel layer. The formation of thisFig. 4. EDX of the pure CHT and of the 70% CHT–30% BG-NP membranes before and
after 5 days immersion in SBF.hydrated silica gel layer on the surface of bioactive glasses which
present abundant silanol (Si–OH) groups provides favorable sites
for calcium phosphate nucleation. Furthermore, the water mole-
cules in SBF react with Si–O–Si bonds to form additional Si–OH
groups. These functional groups then induce apatite nucleation,
which is accelerated by the released Ca2+ and Na+ ions increasing
the ionic activity product of apatite in the ﬂuid. The in vitro bioac-
tivity results are in agreement with previous data reporting the
osteoconductive character of composites containing bioactive
glass/ceramic particles [11,24,28,42]. Kong et al. [21] studied the
bioactivity of CHT/nanohydroxyapatite composite scaffolds and
concluded that the addition of nanohydroxyapatite enhanced the
bone bioactivity of CHT scaffolds.3.4. DNA content and ﬂuorescence staining assay
Preliminary cytotoxicity tests were performed with hPDL on
pure CHT and CHT/BG-NP composite membranes, which conﬁrmed
that neither type of membrane was cytotoxic (data not shown).
The presence of cells on pure CHT and CHT/BG-NPs composite
membranes was demonstrated by a ﬂuorescence staining test
(Fig. 5). Cell proliferation on both types of membranes was evalu-
ated using the PicoGreen assay (Fig. 6).
The DNA concentration associated with cell proliferation
showed that hBMSC presented lower proliferation compared with
hPDL. Such a difference is also observed during the expansion of
Fig. 6. DNA content measurements using (a) hPDL and (b) hBMSC cells on pure CHT
and CHT/BG-NP composite membranes. ⁄⁄P < 0.01.
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showed higher numbers of hPDL than hBMSC on CHT membranes
after 3 days culture. In the case of hBMSC no signiﬁcant differences
were observed in DNA levels between the CHT and CHT/BG-NP
membranes. hPDL proliferated over time on both the CHT and
CHT/BG-NP membranes. By day 28 the amount of DNA in hPDL
was signiﬁcantly higher for the CHT/BG-NP composite membranes.
Some previous studies reporting cell proliferation on bioactive
glass composites also demonstrated that the addition of bioactive
glasses could promote cell proliferation [43–46].
3.5. Alamar blue assay
The Alamar blue assay was performed to determine the relative
differences in metabolic activity between hPDL and hBMSC cul-
tured on pure CHT and CHT/BG-NP composite membranes. Nor-
malization was to the ratio between ﬂuorescence intensity levels
of CHT/BG-NP composite membranes and pure CHT membranes
(see Fig. 7).
Generally cell metabolic activity was higher in the CHT/BG-NP
group compared with the CHT group for both hPDL and hBMSC.
In the case of hBMSC the ratio tended to increase over time. The
Alamar blue results suggest that the metabolic activity of both
kinds of cells was higher on the CHT/BG-NP composite membranes.
Sun et al. [47] used the same assay to show that akermite ceramic,
which is also a bioactive ceramic, promoted hBMSC proliferation.
Some other studies with bioactive glasses have shown that silicon
and other released products promoted the proliferation of different
cell types [45,48–50]. Hong et al. showed that BG-NPs with similar
compositions to those tested in the present study stimulated the
attachment and spreading of bone marrow stem cells [24].
3.6. Calcium content
Calcium formation was analyzed on days 21 and 28 of cell cul-
ture on pure CHT and CHT/BG-NP composite membranes. The dataFig. 5. Fluorescence staining assay 3 days after seeding of hBMSfor day 28 are presented in Fig. 8, including calcium release from
membranes non-seeded with cells (bare membranes).C and hPDL on both the CHT and CHT/BG-NP membranes.
Fig. 7. Ratio of ﬂuorescence intensity between CHT/BG-NP composite membranes
and CHT membranes due to (a) hPDL and (b) hBMSC, obtained from Alamar blue
assays.
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cells on CHT/BG-NP composite membranes was signiﬁcantly high-
er than on pure CHT membranes and control groups, indicating a
positive effect of the presence of BG-NPs on cell mineralization.
The highest calcium contents were found for membranes with
BG-NPs, which could be attributed to the release of calcium from
the inorganic nanoparticles. Dieudonné et al. [51] concluded that
the high base calcium levels of bioactive glasses (in the absence
of cells) could be responsible for the increased mineralization.
However, in the present study the calcium levels on day 28 on
the CHT/BG-NP composite membranes in the presence of cells
were signiﬁcantly higher than on bare composite membranes. This
result indicates that the increased calcium formation could be a re-
sult of cell matrix mineralization. Others studies have demon-
strated that the presence of bioactive glasses can improve cell
mineralization [11,48,52]. On the CHT/BG-NP composite mem-
branes both type of cell showed an increase in calcium levels be-
tween day 21 (data not shown) and day 28, indicating that
mineralized matrix formation occurred over time, which means
that the cells continued to mineralize after 21 days.Fig. 8. Calcium content measurements of hPDL and hBMSC on CHT membranes and
CHT/BG-NP composite membranes, and bare membranes. ⁄⁄⁄P < 0.001; ⁄⁄P < 0.01.4. Conclusion
CHT/BG-NP composite membranes were studied for possible
application as GTR membranes and for GBR, provided by the addi-
tion of BG-NPs to the polymer, promoting the possibility of peri-
odontal regeneration. The introduction of BG-NPs into the CHT
increased the stiffness of the membrane and the composite mem-
branes showed adequate extensibility in wet conditions. Upon
immersion in SBF the composite membranes, but not pure CHT
membranes, were able to promote the deposition of an apatite
layer, evidence of osteoconductive potential. The present study
compared the in vitro biological performance of pure CHT mem-
branes with CHT/BG-NP composite membranes. The metabolic
activity of hPDL and hBMSC was enhanced on the addition of BG-
NPs to CHT membranes. An increase in cell proliferation of hPDL
on CHT/BG-NP composite membranes was veriﬁed compared with
pure CHT membranes. The incorporation of BG-NPs into the mem-
brane promoted greater cell matrix mineralization by both types of
cells.
The CHT/BG-NP composite membranes studied could be used as
barrier membranes to prevent the invasion of periodontal defects
by soft tissues, since these membranes did not show early degrada-
tion and were not cytotoxic. The results obtained suggest the pos-
sible applicability of these composite membranes in GBR and,
consequently, periodontal regeneration.Acknowledgement
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112774/2009.Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Fig. 5, are difﬁcult to
interpret in black and white. The full colour images can be found
in the on-line version, at http://dx.doi.org/10.1016/j.actbio.2012.
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